#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	16300	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2048	791.9	0	.	n	.	0	C1450T	SNP	1450	1450	C	1697	1697	T	939	T,C,G	847,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	16300	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2048	791.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1431	1431	C	975	C	905	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29638	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3644	811.7	0	.	n	.	0	T695C	SNP	695	695	T	1039	1039	C	928	C,T	846,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29638	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3644	811.7	0	.	n	.	0	A1816G	SNP	1816	1816	A	2160	2160	G	955	G,A	877,4	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29638	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3644	811.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2315	2315	C	965	C,T	873,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29638	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3644	811.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2389	2389	A	955	A	887	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29638	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3644	811.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2941	2941	C	901	C	836	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	1974	folP	852	852	99.88	folP.l15.c4.ctg.1	1381	141.5	0	.	p	.	0	E151K	NONSYN	451	453	GAA	659	661	AAA	179;184;182	A;A;A	164;171;171	.	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	1974	folP	852	852	99.88	folP.l15.c4.ctg.1	1381	141.5	1	SNP	p	R228S	0	.	.	682	684	CGC	890	892	CGC	196;199;200	C;G;C	183;186;187	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5324	gyrA	2751	2751	99.78	gyrA.l15.c4.ctg.1	3185	166.3	0	.	p	.	0	M250I	NONSYN	748	750	ATG	944	946	ATA	167;166;166	A;T;A	157;157;157	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5324	gyrA	2751	2751	99.78	gyrA.l15.c4.ctg.1	3185	166.3	0	.	p	.	0	R514H	NONSYN	1540	1542	CGT	1736	1738	CAT	199;195;195	C;A,G;T	173;170,1;171	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5324	gyrA	2751	2751	99.78	gyrA.l15.c4.ctg.1	3185	166.3	1	SNP	p	S91F	0	.	.	271	273	TCC	467	469	TCC	196;194;194	T;C;C	183;184;184	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5324	gyrA	2751	2751	99.78	gyrA.l15.c4.ctg.1	3185	166.3	1	SNP	p	D95G	0	.	.	283	285	GAC	479	481	GAC	199;196;195	G;A;C	188;185;185	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5324	gyrA	2751	2751	99.78	gyrA.l15.c4.ctg.1	3185	166.3	1	SNP	p	D95N	0	.	.	283	285	GAC	479	481	GAC	199;196;195	G;A;C	188;185;185	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	1676	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1448	115.4	1	SNP	p	G45D	1	.	.	133	135	GAC	536	538	GAC	196;198;199	G;A;C	188;185;191	mtrR.WHO_L_00489c:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	834	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1043	79.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	27	6194	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3032	203.8	1	SNP	p	D86N	0	.	.	256	258	GAC	620	622	GAC	248;248;250	G,A;A;C	227,1;223;227	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	27	6194	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3032	203.8	1	SNP	p	S87I	0	.	.	259	261	AGT	623	625	AGT	249;250;250	A,T;G;T	226,1;228;230	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	27	6194	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3032	203.8	1	SNP	p	S87W	0	.	.	259	261	AGT	623	625	AGT	249;250;250	A,T;G;T	226,1;228;230	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	27	6194	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3032	203.8	1	SNP	p	S87R	0	.	.	259	261	AGT	623	625	AGT	249;250;250	A,T;G;T	226,1;228;230	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	27	6194	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3032	203.8	1	SNP	p	S88P	0	.	.	262	264	TCC	626	628	TCC	249;252;252	T;C;C,A	230;232;235,1	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4422	parE	1986	1986	99.95	parE.l6.c17.ctg.1	2526	173.9	0	.	p	.	0	A280V	NONSYN	838	840	GCC	1077	1079	GTC	205;205;207	G,A;T,C;C	184,1;184,1;186	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4422	parE	1986	1986	99.95	parE.l6.c17.ctg.1	2526	173.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1467	1469	GGC	232;231;228	G,A;G;C	204,1;206;204	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	4336	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2212	194.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1144	1146	GCA	228;231;233	G;C;A	203;205;209	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4336	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2212	194.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1147	1149	ATC	233;234;234	A;T;C	210;210;210	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4336	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2212	194.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1159	1161	GTG	223;220;220	G;T;G	203;203;202	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4336	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2212	194.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1159	1161	GTG	223;220;220	G;T;G	203;203;202	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4336	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2212	194.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1663	1665	ACC	221;223;223	A;C;C	197;201;203	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4336	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2212	194.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1717	1719	GCG	238;237;239	G,A;C;G	200,1;191;197	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4336	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2212	194.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1717	1719	GCG	238;237;239	G,A;C;G	200,1;191;197	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4336	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2212	194.8	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1840	1842	GGT	219;223;224	G;G;T	197;201;202	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4336	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2212	194.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1849	1851	GGC	225;221;221	G;G;C	203;198;197	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4336	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2212	194.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1867	1869	CCG	200;201;205	C;C;G	152;174;161	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6254	ponA	2397	2397	99.96	ponA.l15.c30.ctg.1	3161	197.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2250	porA	1146	1146	99.74	porA.l15.c30.ctg.1	1894	118.3	0	.	p	.	0	S22G	NONSYN	64	66	AGC	355	357	GGC	180;179;178	G;G;C	168;168;169	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2250	porA	1146	1146	99.74	porA.l15.c30.ctg.1	1894	118.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	537	537	C	186	C	167	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	356	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	436	30.6	0	.	p	.	0	V258L	NONSYN	772	774	GTA	89	91	TTA	70;70;70	T;T;A	62;62;62	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	356	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	436	30.6	0	.	p	.	0	Y273R	NONSYN	817	819	TAT	134	136	CGT	60;55;55	C;G;T	51;47;48	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	356	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	436	30.6	0	.	p	.	0	D274S	NONSYN	820	822	GAT	137	139	AGT	56;57;56	A;G;T	49;49;49	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	356	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	436	30.6	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	146	148	TAC	57;57;58	T;A;C	49;48;50	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	356	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	436	30.6	0	.	p	.	0	R307E	NONSYN	919	921	AGA	236	238	GAA	20;19;19	G,A;A,G;A	19,1;18,1;19	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	356	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	436	30.6	0	.	p	.	0	T311A	NONSYN	931	933	ACA	248	250	GCA	17;18;18	G,A;C;A	16,1;18;18	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	356	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	436	30.6	0	.	p	.	0	E312D	NONSYN	934	936	GAA	251	253	GAC	18;18;18	G;A;C,A	18;18;17,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	356	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	436	30.6	0	.	p	.	0	F314I	NONSYN	940	942	TTC	257	259	ATC	17;17;17	A,T;T;C	16,1;17;17	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	356	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	436	30.6	0	.	p	.	0	A316S	NONSYN	946	948	GCG	263	265	TCG	16;16;16	T,G;C;G	15,1;16;16	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	356	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	436	30.6	0	.	p	.	0	V318A	NONSYN	952	954	GTC	269	271	GCC	15;14;14	G;C;C	14;14;14	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	356	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	436	30.6	0	.	p	.	0	G319S	NONSYN	955	957	GGC	272	274	AGC	14;14;14	A;G;C	14;14;14	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	356	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	436	30.6	0	.	p	.	0	G320A	NONSYN	958	960	GGT	275	277	GCC	13;13;13	G;C;C	12;13;13	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	356	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	436	30.6	0	.	p	.	0	G322V	NONSYN	964	966	GGT	281	283	GTT	12;12;12	G;T;T	12;12;12	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3326	porB1b	1035	1035	97.71	porB1b.l15.c17.ctg.1	1520	217.9	0	.	p	.	0	E38G	NONSYN	112	114	GAA	441	443	GGA	289;284;285	G;G;A	262;258;254	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3326	porB1b	1035	1035	97.71	porB1b.l15.c17.ctg.1	1520	217.9	0	.	p	.	0	G46S	NONSYN	136	138	GGC	465	467	AGC	276;277;279	A;G;C	257;259;257	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3326	porB1b	1035	1035	97.71	porB1b.l15.c17.ctg.1	1520	217.9	0	.	p	.	0	V98I	NONSYN	292	294	GTC	621	623	ATC	264;264;267	A;T;C	238;235;241	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3326	porB1b	1035	1035	97.71	porB1b.l15.c17.ctg.1	1520	217.9	0	.	p	.	0	A121V	NONSYN	361	363	GCC	690	692	GTC	273;273;273	G;T;C	253;248;252	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3326	porB1b	1035	1035	97.71	porB1b.l15.c17.ctg.1	1520	217.9	0	.	p	.	0	R143E	NONSYN	427	429	AGA	756	758	GAA	278;281;282	G;A;A	254;257;257	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3326	porB1b	1035	1035	97.71	porB1b.l15.c17.ctg.1	1520	217.9	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	960	960	T	292	T	273	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12408	rpoB	4179	4179	99.95	rpoB.l15.c17.ctg.1	4786	258.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1320	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	983	133.4	1	SNP	p	V57M	1	.	.	169	171	ATG	510	512	ATG	293;293;292	A;T;G	268;267;261	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
